Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-08-15 01:20 | 2014-08-13 | EOPN | N/A | MOORE NICHOLAS G | Director | Other | OPT+S | $15.46 | 54,998 | $850,506 | 10,600 | -83.8% |
| 2014-07-30 19:17 | 2014-07-28 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $90.56 | 45,000 | $4,075,403 | 0 | -100.0% |
| 2014-02-28 20:50 | 2014-02-26 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $84.05 | 20,000 | $1,681,070 | 0 | -100.0% |
| 2014-02-21 22:32 | 2014-02-19 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $83.12 | 19,068 | $1,584,989 | 0 | -100.0% |
| 2014-02-22 02:26 | 2014-02-19 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $40.63 | 50,000 | $2,031,655 | 0 | -100.0% |
| 2013-09-05 02:09 | 2013-08-30 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $60.42 | 151,720 | $9,166,589 | 0 | -100.0% |
| 2012-12-05 00:51 | 2012-11-30 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $74.96 | 65,000 | $4,872,550 | 7,309 | -89.9% |
| 2012-02-10 23:27 | 2012-02-08 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $54.29 | 65,000 | $3,528,766 | 7,226 | -90.0% |
| 2010-08-24 01:32 | 2010-08-20 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $40.38 | 40,000 | $1,615,212 | 0 | -100.0% |
| 2009-12-31 20:59 | 2009-12-29 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $33.68 | 20,000 | $673,618 | 0 | -100.0% |
| 2008-02-28 22:27 | 2008-02-26 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | SALE | $43.95 | 5,900 | $259,319 | 0 | -100.0% |
| 2008-02-28 22:21 | 2008-02-26 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $43.69 | 42,100 | $1,839,202 | 5,900 | -87.7% |
| 2006-11-22 03:44 | 2006-11-17 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | SALE | $68.24 | 1,735 | $118,388 | 0 | -100.0% |
| 2006-11-22 03:43 | 2006-11-17 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $68.69 | 28,285 | $1,942,761 | 1,735 | -94.2% |
| 2006-11-21 02:38 | 2006-11-17 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $39.75 | 20,000 | $795,000 | 0 | -100.0% |
| 2006-03-27 21:53 | 2006-03-24 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $35.10 | 20,000 | $702,000 | 0 | -100.0% |
| 2005-11-23 01:26 | 2005-11-21 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $54.07 | 36,000 | $1,946,365 | 0 | -100.0% |
| 2005-08-08 18:50 | 2005-08-04 | STRRP | Star Equity Holdings, Inc. | MOORE NICHOLAS G | Director | Services-Help Supply Services | BUY | $21.06 | 339 | $7,136 | 339 | +100.0% |
| 2005-05-06 01:20 | 2005-05-04 | GILD | GILEAD SCIENCES, INC. | MOORE NICHOLAS G | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $38.68 | 30,000 | $1,160,280 | 0 | -100.0% |
| 2004-12-09 22:45 | 2004-12-07 | NTAP | NetApp, Inc. | MOORE NICHOLAS G | Director | Computer Storage Devices | OPT+S | $33.66 | 35,000 | $1,178,205 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.